Published in:
Open Access
01-12-2017 | Editorial
Towards precision medicine for sepsis patients
Authors:
Peter Pickkers, Matthijs Kox
Published in:
Critical Care
|
Issue 1/2017
Login to get access
Excerpt
Over the last decade it has become clear that the immunological response and clinical course in sepsis patients is too complex to simply regard it as ‘hyperinflammation-induced organ failure’. In contrast to the previous belief that patients mainly suffer from an exaggerated pro-inflammatory response, it has now become evident that a pro- and anti-inflammatory response are mounted simultaneously [
1,
2]. Whether pro-inflammation or anti-inflammation is the overruling immune response may differ between patients and evolve over time in an individual patient [
2], and this may explain why all previous clinical studies in sepsis patients using interventions to attenuate the immune response are negative [
3]. Greater appreciation for the role of the
dysregulated immune response is represented in the new definition of sepsis [
4], defining sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection. …